Netflix Swings After Reporting… And Trump Takes Aim At Powell 4/17/25
CNBC's "Fast Money"
Eli Lilly's Obesity Pill: A Game Changer in Diabetes Treatment
This chapter explores the rise of Eli Lilly's stock due to positive late-stage trial results for its obesity pill aimed at type 2 diabetes patients. It examines the pill's advantages, expert insights on patient preferences, and the critical role of pricing in its market performance.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
